CLINICAL_TRIALS trial_result · 2024-06-27

Clinical Trial Update: PET Imaging of Cyclooxygenase in Multiple Sclerosis [Phase 2]

A Phase 2 trial evaluating PET imaging of cyclooxygenase in people with multiple sclerosis was terminated; results were posted on 2024-06-27.

Upgrade for the full analysis, importance score, and drug timeline.

Sponsor: National Institute of Mental Health (NIMH) | Conditions: Multiple Sclerosis | Phase 2 | Status: TERMINATED | Results posted: 2024-06-27